JIUN-KAE JACK LEE to Etoposide
This is a "connection" page, showing publications JIUN-KAE JACK LEE has written about Etoposide.
Connection Strength
0.033
-
Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol. 2012 May; 7(5):825-32.
Score: 0.021
-
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer. Clin Lung Cancer. 2003 Jul; 5(1):40-5.
Score: 0.012